Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV‐1–Positive Persons in Uganda
Citations Over TimeTop 10% of 2002 papers
Abstract
The effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression was investigated in 1045 adults in Uganda. At enrollment and every 6 months, a clinical history, examination, and laboratory investigations that included CD4 cell counts were done. HIV-1 envelope subtype was assessed mainly by peptide serology supplemented by heteroduplex mobility assay and DNA sequencing. A multivariate analysis of survival was performed to assess the prognostic value of HIV-1 subtype on death. A marginal general linear model also determined the effect of subtype on CD4 cell count during follow-up. Subtype D was associated with faster progression to death (relative risk, 1.29; 95% confidence interval, 1.07-1.56; P=.009) and with a lower CD4 cell count during follow-up (P=.001), compared with subtype A, after adjusting for CD4 cell count at enrollment. In Africa, envelope subtype D is associated with faster disease progression, compared with subtype A.
Related Papers
- → Chagas' disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods.(1999)146 cited
- → Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: A potential human reservoir of parasites?(2006)68 cited
- → Serological markers for coeliac disease(1998)25 cited
- → Echotomographic and serological population-based study of hydatidosis in Central Tunisia(1991)31 cited
- → Helicobacter pylori Serology: Kit Evaluation and Comparison(1994)1 cited